Showing results (1471-1480 of 1,496) with videos related to
Sort By:
Pageof 150
Experimental Dermatology|June 19, 2026
Serum DSDNA is Associated With PsoriasisQi Zhen, Na Yin, Weiwei Chen, et al.Scientific Reports|March 6, 2015
Excess of rare variants in genes that are key epigenetic regulators of spermatogenesis in the patients with non-obstructive azoospermiaZesong Li, Yi Huang, Honggang Li, et al.Molecular Cancer Therapeutics|April 2, 2014
A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor modelsTinggui Yin, Maria J Lallena, Emiko L Kreklau, et al.Molecular Cancer Therapeutics|March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination PartnersAatman S Doshi, Susan Cantin, Marylens Hernandez, et al.International Immunopharmacology|September 26, 2024
Serum dsDNA is environmentally contingentQi Zhen, Weiwei Chen, Yang Han, et al.Journal of Bio-X Research|July 13, 2021
Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world studySong Fan, Qi Zhen, Cheng Chen, et al.Nature Cell Biology|January 9, 2021
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progressionSujun Chen, Guanghui Zhu, Yue Yang, et al.Plos Genetics|April 20, 2016
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung CancerLiyan Jiang, Jiaqi Huang, Brandon W Higgs, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 21, 2017
MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder CancerHai-Bin Liang, Yang Cao, Qiang Ma, et al.Scientific Reports|June 2, 2026
Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008)Jin-Wei Wu, Da-Long Yang, Shu-Chang Chen, et al.Pageof 150